Xyrem (GHB, Gamma-Hydroxybutyrate), Clinical testing of

The drug development company, Orphan Medical, Inc., is conducting clinical testing of Xyrem as a medication for treating the symptoms of narcolepsy. The current study will last about 16 weeks. Participants will not be required to discontinue the use of medications for controlling excessive daytime sleepiness. Volunteers are needed to participate in these clinical tests at the sites linked below.

Click on a red X in map below to get info about testing at that site (click here for a larger map).

or click on one of the state/city combinations listed below.

ADDITIONAL TEST SITES - US & CANADA: It is likely that additional test sites in both the US and in Canada will soon be added to this list, so check back from time-to-time or use our MultiPurpose Guest Book / notification page (above) to indicate your interest and we will notify you by e-mail when test sites near you are added.

posted Jan. 10, 2001, updated June 2,, 2001